Ripretinib inhibits HIV-1 transcription through modulation of PI3K-AKT-mTOR
Jinfeng Cai(Sun Yat-sen University), Kai Deng(Sun Yat-sen University)
Cited by 8
Related Papers
Ponatinib Represses Latent HIV-1 by Inhibiting AKT-mTOR
|Antimicrobial Agents and Chemotherapy|2023|14
Proteasome and PARP1 dual-target inhibitor for multiple myeloma: Fluzoparib
|Biochemistry and Biophysics Reports|2024|2